Back to top
more

Genetic Technologies Ltd (GENE)

(Delayed Data from NSDQ)

$3.66 USD

3.66
290,497

+0.10 (2.81%)

Updated Jul 26, 2021 04:00 PM ET

Pre-Market: $4.23 +0.57 (15.57%) 9:08 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy25.57%
2Buy19.14%
3Hold10.74%
4Sell6.46%
5Strong Sell3.16%
S&P50011.27%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

NA Value NA Growth NA Momentum NA VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 15% (215 out of 252)

Industry: Medical - Biomedical and Genetics

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Trades from $1

Balance Sheet

Fiscal Year End for Genetic Technologies Ltd falls in the month of June.

All items in Millions except Per Share data.

6/30/2021 6/30/2020 6/30/2019 6/30/2018 6/30/2017
Assets          
Cash & Equivalents NA 10 2 4 8
Receivables NA 1 1 0 0
Notes Receivable NA 0 0 0 0
Inventories NA 0 0 0 0
Other Current Assets NA 0 0 0 0
Total Current Assets NA 10 2 5 9
Net Property & Equipment NA 0 0 0 0
Investments & Advances NA 0 0 0 0
Other Non-Current Assets NA 0 0 0 0
Deferred Charges NA 0 0 0 0
Intangibles NA 0 0 0 0
Deposits & Other Assets NA 0 0 0 0
Total Assets NA 11 2 5 9
Liabilities & Shareholders Equity 6/30/2021 6/30/2020 6/30/2019 6/30/2018 6/30/2017
Notes Payable NA 0 0 0 0
Accounts Payable NA 0 1 1 1
Current Portion Long-Term Debt NA 0 0 0 0
Current Portion Capital Leases NA 0 0 0 0
Accrued Expenses NA 0 0 0 0
Income Taxes Payable NA 0 0 0 0
Other Current Liabilities NA 0 0 0 0
Total Current Liabilities NA 1 1 1 1
Mortgages NA 0 0 0 0
Deferred Taxes/Income NA 0 0 0 0
Convertible Debt NA 0 0 0 0
Long-Term Debt NA 0 0 0 0
Non-Current Capital Leases NA 0 0 0 0
Other Non-Current Liabilities NA 1 0 0 0
Minority Interest (Liabilities) NA 0 0 0 0
Total Liabilities NA 2 1 1 1
Shareholders Equity 6/30/2021 6/30/2020 6/30/2019 6/30/2018 6/30/2017
Preferred Stock NA 0 0 0 0
Common Stock (Par) NA 0 0 0 0
Capital Surplus NA 0 0 0 0
Retained Earnings NA -91 -93 -96 -89
Other Equity NA 100 94 99 97
Treasury Stock NA 0 0 0 0
Total Shareholder's Equity NA 9 1 4 8
Total Liabilities & Shareholder's Equity NA 11 2 5 9
Total Common Equity 0 9 1 4 8
Shares Outstanding 15.00 13.50 4.90 4.00 4.00
Book Value Per Share 0.00 0.65 0.26 0.91 2.00

Fiscal Year End for Genetic Technologies Ltd falls in the month of June.

All items in Millions except Per Share data.

6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Assets          
Cash & Equivalents NA NA 12 NA 10
Receivables NA NA 1 NA 1
Notes Receivable NA NA NA NA 0
Inventories NA NA 0 NA 0
Other Current Assets NA NA 0 NA 0
Total Current Assets NA NA 13 NA 10
Net Property & Equipment NA NA 0 NA 0
Investments & Advances NA NA NA NA 0
Other Non-Current Assets NA NA NA NA 0
Deferred Charges NA NA NA NA 0
Intangibles NA NA NA NA 0
Deposits & Other Assets NA NA 0 NA 0
Total Assets NA NA 14 NA 11
Liabilities & Shareholders Equity 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Notes Payable NA NA NA NA 0
Accounts Payable NA NA 0 NA 0
Current Portion Long-Term Debt NA NA NA NA 0
Current Portion Capital Leases NA NA 0 NA 0
Accrued Expenses NA NA NA NA 0
Income Taxes Payable NA NA NA NA 0
Other Current Liabilities NA NA 0 NA 0
Total Current Liabilities NA NA 1 NA 1
Mortgages NA NA NA NA 0
Deferred Taxes/Income NA NA NA NA 0
Convertible Debt NA NA NA NA 0
Long-Term Debt NA NA 0 NA 0
Non-Current Capital Leases NA NA 0 NA 0
Other Non-Current Liabilities NA 0 NA 1
Minority Interest (Liabilities) NA NA NA NA 0
Total Liabilities NA NA 1 NA 2
Shareholders Equity 6/30/2021 3/31/2021 12/31/2020 9/30/2020 6/30/2020
Preferred Stock NA NA NA NA 0
Common Stock (Par) NA NA 108 NA 0
Capital Surplus NA NA NA NA 0
Retained Earnings NA NA -102 NA -91
Other Equity NA NA 7 NA 100
Treasury Stock NA NA NA NA 0
Total Shareholder's Equity NA NA 13 NA 9
Total Liabilities & Shareholder's Equity NA NA 14 NA 11
Total Common Equity 0 0 100,012 0 9
Shares Outstanding 15.00 15.00 13.50 13.50 13.50
Book Value Per Share 0.00 0.00 7,408.28 0.00 0.65